AAAAAA

   
Results: 1-11 |
Results: 11
Intratracheal administration of recombinant human factor IX (BeneFix (TM))achieves therapeutic levels in hemophilia B dogs
Authors: Russell, KE Read, MS Bellinger, DA Leitermann, K Rup, BJ McCarthy, KP Keith, JC Khor, SP Schaub, RG Nichols, TC
Citation: Ke. Russell et al., Intratracheal administration of recombinant human factor IX (BeneFix (TM))achieves therapeutic levels in hemophilia B dogs, THROMB HAEM, 85(3), 2001, pp. 445-449
In memoriam: Kenneth M. Brinkhous (1908-2000) - Obituary
Authors: Roberts, HR White, GC Wagner, RH Nichols, TC Read, MS
Citation: Hr. Roberts et al., In memoriam: Kenneth M. Brinkhous (1908-2000) - Obituary, THROMB RES, 102(5), 2001, pp. 385-386
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
Authors: Wang, LL Nichols, TC Read, MS Bellinger, DA Verma, IM
Citation: Ll. Wang et al., Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver, MOL THER, 1(2), 2000, pp. 154-158
Lyophilized platelets: continued development
Authors: Bode, AP Read, MS
Citation: Ap. Bode et Ms. Read, Lyophilized platelets: continued development, TRANSFUS SC, 22(1-2), 2000, pp. 99-105
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony
Authors: Herzog, RW Arruda, VR Fisher, TH Read, MS Nichols, TC High, KA
Citation: Rw. Herzog et al., Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony, THROMB HAEM, 84(2), 2000, pp. 352-354
Intracellular function in rehydrated lyophilized platelets
Authors: Fischer, TH Merricks, EP Russell, KE Raymer, RA White, GC Bode, AP Nichols, TC Read, MS
Citation: Th. Fischer et al., Intracellular function in rehydrated lyophilized platelets, BR J HAEM, 111(1), 2000, pp. 167-174
Lyophilized platelets for transfusion
Authors: Bode, AP Read, MS
Citation: Ap. Bode et Ms. Read, Lyophilized platelets for transfusion, PLATELET THERAPY: CURRENT STATUS AND FUTURE TRENDS, 2000, pp. 131-167
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
Authors: Herzog, RW Yang, EY Couto, LB Hagstrom, JN Elwell, D Fields, PA Burton, M Bellinger, DA Read, MS Brinkhous, KM Podsakoff, GM Nichols, TC Kurtzman, GJ High, KA
Citation: Rw. Herzog et al., Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, NAT MED, 5(1), 1999, pp. 56-63
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
Authors: Snyder, RO Miao, C Meuse, L Tubb, J Donahue, BA Lin, HF Stafford, DW Patel, S Thompson, AR Nichols, T Read, MS Bellinger, DA Brinkhous, KM Kay, MA
Citation: Ro. Snyder et al., Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors, NAT MED, 5(1), 1999, pp. 64-70
Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber
Authors: Bode, AP Read, MS Reddick, RL
Citation: Ap. Bode et al., Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber, J LA CL MED, 133(2), 1999, pp. 200-211
Failure to achieve gene conversion with chimeric circular oligonucleotides: Potentially misleading PCR artifacts observed
Authors: Zhang, ZP Eriksson, M Falk, G Graff, C Presnell, SC Read, MS Nichols, TC Blomback, M Anvret, M
Citation: Zp. Zhang et al., Failure to achieve gene conversion with chimeric circular oligonucleotides: Potentially misleading PCR artifacts observed, ANTISENSE N, 8(6), 1998, pp. 531-536
Risultati: 1-11 |